GPX4 and COVID-19: 257,258 N-acetylcysteine (NAC), a precursor of GSH, possesses anti-ferroptosis activity through directly reinforcing the cystine-GSH-GPX4 axis259 and reducing the IL-6-promoted ROS production,260 accounting for a part of its effects for COVID-19 treatment.